Rare diseases
Investigational molecules
Locations
359 conditions with trials, the busiest first
849 trials across Europe, recruiting first
Study on Guselkumab and Etanercept for Treating Chronic Plaque Psoriasis in Children Aged 6 to 17 Years
BelgiumStudy on the Safety and Effectiveness of TP-102 for Treating Diabetic Foot Infections in Patients
PolandStudy on the Effectiveness and Safety of Oral Minoxidil for Women with Androgenetic Alopecia
GermanyStudy on the Safety and Effectiveness of Pembrolizumab, Lenvatinib, and Quavonlimab for Patients with Advanced Melanoma with Brain Metastases
FranceStudy on Frexalimab for Treating Active Systemic Lupus Erythematosus in Patients
GreeceLong-term Safety Study of Miransertib for Patients with PIK3CA-related Overgrowth Spectrum or Proteus Syndrome
ItalyStudy on Tofacitinib for Patients with Mycosis Fungoides
DenmarkStudy on Optimizing Ciclosporin Treatment for Moderate to Severe Atopic Dermatitis in Adults, Adolescents, and Children
SpainStudy of LTX-315 and Pembrolizumab for Patients with Advanced Melanoma Resistant to PD-1/PD-L1 Therapy
FranceStudy on Botensilimab and Balstilimab for Patients with Advanced Melanoma Resistant to Previous Treatments
BelgiumStudy on Treating Keratolytic Winter Erythema in Adults Using Nitroxoline
NorwayStudy of Linperlisib for Patients with Relapsed or Refractory Peripheral T/NK Cell or Cutaneous T Cell Lymphoma
ItalyThe therapies tested most often in Skin and subcutaneous tissue disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
